How to continue Topamax after moving to Texas

If you’re struggling with Binge Eating Disorder (BED), you may have wondered whether you can access treatment—including medication—through telehealth. The short answer is yes, and in most cases, you won’t need an in-person visit to get started. This guide breaks down everything you need to know about getting BED medication online, the regulations that make it possible, and what to expect from the process.

Understanding Telehealth Access for BED Medications

The Basics: What Medications Are We Talking About?

While only one medication (Vyvanse, a controlled stimulant) has FDA approval specifically for Binge Eating Disorder, healthcare providers commonly prescribe two non-controlled medications off-label to help manage BED symptoms:

• Topamax (topiramate) – Originally approved for seizures and migraines, this medication has shown effectiveness in reducing binge eating episodes and can help with impulse control
• Wellbutrin (bupropion) – FDA-approved for depression and smoking cessation, research suggests it can help reduce binge frequency in some patients

The critical distinction here is that both of these are non-controlled substances. This matters enormously for telehealth access, because federal restrictions on remote prescribing primarily target controlled medications like stimulants and opioids—not medications like Topamax or Wellbutrin.

Federal Law: The Green Light for Telehealth Prescribing

At the federal level, the Ryan Haight Act regulates online prescribing of controlled substances and requires an in-person medical evaluation before controlled medications can be prescribed via telemedicine. However, this law never applied to non-controlled medications. That means medications like topiramate and bupropion have always been legally prescribable via telehealth, even before the pandemic.

During COVID-19, the DEA created temporary flexibilities that allowed controlled substance prescribing via telehealth without an initial in-person visit. These flexibilities have been extended multiple times—most recently through December 31, 2026—while permanent regulations are being finalized. But for your BED treatment with non-controlled medications, these controlled-substance rules aren’t even relevant. Your access to Topamax or Wellbutrin through telehealth is not dependent on any temporary waiver or emergency rule.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Considerations: Where You Can Get Treatment

While federal law sets the baseline, individual states add their own requirements for telehealth prescribing. The good news? Most states now allow telehealth prescribing of non-controlled medications without requiring an in-person visit.

States with No In-Person Requirements

The majority of states—including California, New York, Delaware, Florida, Texas, Michigan, Wisconsin, and South Carolina—have no mandatory in-person examination requirement for non-controlled medication prescribing via telehealth. In these states, your telehealth provider can conduct a comprehensive video evaluation and prescribe appropriate BED medications if clinically indicated.

California has been particularly progressive, with 2025 legislation (AB 1503) explicitly clarifying that a ‘good faith examination’ can include asynchronous telehealth encounters, meaning even questionnaire-based assessments can suffice if they meet the standard of care.

States Requiring Periodic In-Person Follow-Ups

A handful of states ask for periodic in-person contact for ongoing telehealth treatment:

• Alabama: After four telehealth visits within 12 months for the same condition, patients should be seen in-person within one year (though this can be satisfied by any collaborating provider)
• Georgia: Requires attempting an in-person exam at least annually for continued telemedicine care
• New Hampshire: Recently updated laws to allow telehealth initiation, but requires an in-person follow-up within 12 months for Schedule II-IV controlled substances (non-controlled medications have more flexibility)

Even in these states, you can typically start treatment entirely online—the in-person requirement applies only to long-term continuation of care.

Who Can Prescribe: Understanding Provider Credentials

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathy can prescribe BED medications via telehealth in all 50 states, as long as they’re licensed in your state of residence.

Nurse Practitioners (NPs)

The landscape for Nurse Practitioners has evolved dramatically. As of 2025, 34 states plus Washington D.C. grant NPs Full Practice Authority, meaning they can evaluate patients and prescribe medications independently without physician oversight. Recent additions to this list include:

• Michigan (expanded NP scope in 2025 under Public Act 47 of 2023)
• Wisconsin (APRN Modernization Act passed August 2025)
• Louisiana and Kansas (joined in 2023-2024)

In states with Full Practice Authority—like California, New York, New Hampshire, Delaware, Michigan, and Wisconsin—your NP can provide complete BED care via telehealth without any physician involvement.

In other states like Florida, Texas, Georgia, and Alabama, NPs work under collaborative agreements with physicians. Practically, this doesn’t usually impact your care experience—your NP can still evaluate you via telehealth and prescribe Topamax or Wellbutrin, but they do so under a formal supervision arrangement with a physician.

Physician Assistants (PAs)

PAs can prescribe these non-controlled medications in all states, though they typically work under physician supervision. The PA’s supervising physician doesn’t need to be present during your telehealth visit, but there’s a formal delegation agreement in place.

At Klarity Health, our network includes board-certified physicians and experienced psychiatric nurse practitioners who can evaluate you for BED and prescribe appropriate medications where clinically indicated—all through convenient telehealth visits.

The Telehealth Evaluation Process: What to Expect

Initial Assessment

A legitimate telehealth evaluation for BED medication should be thorough—typically 30 minutes or longer for an initial consultation. Your provider will:

• Review your eating behaviors in detail, looking for the core diagnostic criteria of BED
• Ask about binge eating episodes (eating an unusually large amount within about 2 hours, feeling out of control)
• Determine frequency (BED requires at least weekly episodes for three months)
• Screen for compensatory behaviors like purging (which would suggest a different eating disorder)
• Take a comprehensive medical and psychiatric history
• Review current medications and any previous treatments
• Discuss treatment goals and expectations

Documentation and Consent

Your provider will document that you meet DSM-5 criteria for Binge Eating Disorder and that they’ve obtained your informed consent for both telehealth care and the specific medication being prescribed. Many providers use standardized questionnaires like the Eating Disorder Examination Questionnaire (EDE-Q) or the Binge Eating Scale (BES) to establish baseline severity.

Identity and Location Verification

Don’t be surprised if your provider asks to verify your identity and location at the start of the visit. This isn’t about mistrust—many states explicitly require that telehealth providers confirm they’re treating patients in states where they’re licensed. It’s a protective measure for both you and the provider.

Prescription Monitoring Programs (PMPs): What You Should Know

Many patients worry about Prescription Drug Monitoring Program checks. Here’s the reality: most states only mandate PMP checks for controlled substances. Since Topamax and Wellbutrin aren’t controlled medications, your state’s PMP laws typically don’t require your provider to check the database before prescribing them.

That said, responsible telehealth providers may still review your medication history as a precaution—for example, to ensure you’re not on another bupropion prescription from a different provider, or to check for potential drug interactions. This is good clinical practice, not a legal requirement.

Safety Considerations: Who Shouldn’t Get BED Medication via Telehealth

Telehealth is convenient and effective for many people, but it’s not appropriate for everyone. Your provider will screen for conditions that would make remote treatment unsafe:

Contraindications for Wellbutrin (Bupropion)

• History of eating disorders with purging: Wellbutrin is contraindicated in patients with bulimia or anorexia nervosa due to increased seizure risk
• Seizure disorders: Bupropion lowers the seizure threshold and should not be used if you have epilepsy or other seizure conditions
• Abrupt discontinuation of alcohol or sedatives: This combination increases seizure risk
• MAOI use: Wellbutrin cannot be combined with MAO inhibitors

Contraindications for Topamax (Topiramate)

• Pregnancy or planning pregnancy: Topiramate is linked to birth defects including cleft palate and should be avoided during pregnancy
• Uncontrolled glaucoma: Topiramate can increase eye pressure
• Metabolic acidosis risk: Patients with kidney disease need careful monitoring

When You Need In-Person Care

Telehealth providers will typically refer you for in-person evaluation if:

• You have severe medical complications from BED requiring physical examination
• You need controlled medications (like Vyvanse) that have stricter telehealth restrictions
• You’re medically unstable (severe uncontrolled diabetes, cardiovascular issues, etc.)
• You have complex psychiatric conditions requiring higher levels of care
• You’re experiencing medical emergencies related to your eating disorder

Understanding Off-Label Prescribing

You might notice that neither Topamax nor Wellbutrin is FDA-approved specifically for Binge Eating Disorder. This is completely normal and legal. Off-label prescribing—using FDA-approved medications for conditions other than their approved indication—is standard medical practice and accounts for a significant portion of all prescriptions written.

Research supports the use of both medications for BED:

• Clinical studies have shown topiramate can reduce binge eating frequency and support weight management goals
• Bupropion has demonstrated effectiveness in reducing binge episodes and addressing comorbid depression, which often accompanies BED

Your telehealth provider should explain that they’re prescribing off-label, discuss the evidence supporting this use, and document your informed consent. Don’t hesitate to ask questions about why a particular medication is recommended and what alternatives exist.

The Prescription Process: From Evaluation to Pharmacy

How Prescriptions Are Sent

After your evaluation, if medication is prescribed, your provider will send the prescription electronically to the pharmacy of your choice. This is now standard practice and required in many states. You’ll pick up your medication from a regular retail or mail-order pharmacy—legitimate telehealth services don’t ship you medication directly from their own warehouses for these prescription drugs.

Typical Supply and Refills

Because Topamax and Wellbutrin aren’t controlled substances, providers can typically authorize:

• Initial supply: Usually 30 or 90 days
• Refills: Often up to 6-11 months of refills, depending on state regulations

However, expect regular follow-up appointments, especially when starting treatment. A typical schedule might be:

• Initial evaluation
• 2-week check-in to assess tolerability
• Monthly follow-ups for the first few months
• Then every 2-3 months once stable

Dosing and Titration

Both medications typically start at low doses and are gradually increased:

• Topiramate: Often started at 25mg daily, gradually increased over weeks to target dose (commonly 75-200mg/day for BED)
• Bupropion: Usually started at 150mg XL once daily, may be increased to 300mg after a few weeks

Your provider will give you specific instructions about titration. Never adjust doses on your own—particularly with topiramate, which requires gradual tapering if discontinued to prevent seizures.

Monitoring and Follow-Up Care

What Your Provider Will Track

During follow-up visits, your provider will monitor:

• Effectiveness: Are your binge eating episodes decreasing?
• Side effects: How are you tolerating the medication?
• Weight and metabolic parameters: Changes in weight, blood sugar (if diabetic), blood pressure
• Mental health: Mood changes, suicidal thoughts (particularly important with antidepressants like Wellbutrin)
• Adherence: Are you taking the medication as prescribed?

Laboratory Monitoring

Some providers may request baseline lab work before starting medications:

• Metabolic panel (kidney and liver function, electrolytes)
• Thyroid function tests
• Pregnancy test (for topiramate in women of childbearing potential)

Follow-up labs may be needed depending on the medication and your individual health status.

When to Contact Your Provider Between Visits

Reach out immediately if you experience:

• Signs of allergic reaction (rash, difficulty breathing)
• Seizures
• Severe mood changes or suicidal thoughts
• Unusual bleeding or bruising
• Vision changes (especially with topiramate)
• Symptoms of metabolic acidosis (rapid breathing, confusion, fatigue)

Quality telehealth platforms offer messaging systems or nurse lines for questions between appointments.

Red Flags: How to Identify Questionable Telehealth Services

The telehealth boom has attracted both excellent providers and some concerning operators. Here’s how to identify quality care:

Good Signs

• Comprehensive evaluation: 30+ minute initial consultation with detailed questions
• Discussion of alternatives: Provider mentions therapy, nutrition counseling, or other treatment options—not just medication
• Clear consent process: Written information about telehealth limitations, medication risks, and treatment alternatives
• Reasonable follow-up: Scheduled check-ins, not just ‘call if you need refills’
• Licensed pharmacies: Prescriptions sent to regular pharmacies, not shipped directly from the telehealth company
• Transparent pricing: Clear costs for visits and any subscription fees

Red Flags

• Prescription guaranteed before evaluation: No legitimate provider promises medication without assessment
• Minimal evaluation: 5-10 minute questionnaire leading directly to prescription
• No discussion of risks or alternatives: Focus only on ‘quick fixes’
• Controlled substance focus: Services heavily promoting ADHD stimulants or other controlled medications online (these have much stricter legal requirements)
• Direct medication sales: Company wants to sell you pills directly rather than using a pharmacy
• Pressure tactics: ‘Limited time offers’ or urgent messaging to get you to sign up

The high-profile case of Done Global in 2024—where executives were indicted for allegedly running an ADHD medication ‘pill mill’ that contributed to stimulant shortages—illustrates what can go wrong with poorly regulated telehealth. Choose providers who prioritize thorough evaluation and ongoing care over quick prescriptions.

Recent Regulatory Developments (2025-2026)

Federal Updates

The DEA extended pandemic-era telehealth flexibilities for controlled substances through December 31, 2026, while working on permanent regulations. This doesn’t directly affect BED medications like Topamax and Wellbutrin (which were never restricted), but it signals the government’s commitment to maintaining telehealth access broadly.

State-Level Changes

Several states updated their telehealth laws in 2025:

• New Hampshire (SB 252): Explicitly allowed telehealth prescribing of Schedule II-IV medications with annual in-person follow-up, removing previous barriers
• Delaware (SB 101): Clarified that telemedicine is allowed for medication-assisted treatment of opioid use disorder, resolving prior legal conflicts
• New York: Adopted regulations requiring in-person exams before prescribing controlled substances (once federal waivers end), but this doesn’t affect non-controlled BED medications
• Wisconsin and Michigan: Both granted full practice authority to nurse practitioners, expanding prescriber availability

These changes generally expand access or provide regulatory clarity, making telehealth more stable long-term.

Insurance Coverage and Costs

Insurance Acceptance

Most major insurance plans now cover telehealth visits at parity with in-person care, thanks to state and federal parity laws that were made permanent in many jurisdictions post-pandemic. Your telehealth BED evaluation and follow-up visits should be covered similarly to office visits.

Klarity Health accepts most major insurance plans and also offers transparent cash-pay pricing for those without coverage or who prefer not to use insurance. Our pricing is clearly displayed upfront—no surprise bills.

Medication Costs

The medications themselves (Topamax and Wellbutrin) are both available as generics (topiramate and bupropion), making them relatively affordable:

• Generic topiramate: Often $10-30/month with insurance; $20-60/month without
• Generic bupropion XL: Often $10-40/month with insurance; $30-80/month without

GoodRx and similar discount programs can help reduce costs if you’re paying cash.

Beware of ‘Subscription’ Models

Some telehealth companies charge monthly subscription fees on top of visit costs and medication expenses. Make sure you understand the total cost structure before committing. Traditional fee-for-service models (pay per visit) are often more economical if you don’t need frequent appointments.

Comparing Telehealth to Traditional In-Person Care

Advantages of Telehealth for BED

• Accessibility: Especially valuable in rural areas or for people with limited mobility
• Convenience: No travel time, easier to schedule around work
• Reduced stigma: Some people feel more comfortable discussing eating disorders from home
• Continuity: Easier to maintain care if you move or travel
• Specialist access: Connect with BED specialists who may not practice locally

When In-Person Care May Be Better

• Complex medical needs: Multiple comorbid conditions requiring physical examination
• Severe cases: BED with serious medical complications
• Need for controlled medications: Vyvanse (the only FDA-approved BED medication) has stricter telehealth requirements
• Preference for face-to-face: Some people simply prefer in-person interaction
• Multidisciplinary care: In-person programs may offer integrated teams (psychiatrist, dietitian, therapist in one location)

The ideal approach may be hybrid care—initial telehealth evaluation and medication management combined with in-person therapy, nutrition counseling, or support groups.

Comprehensive BED Treatment: Beyond Medication

While this guide focuses on medication access via telehealth, it’s important to emphasize that medication is just one component of BED treatment. The most effective approach typically includes:

Evidence-Based Psychotherapy

• Cognitive Behavioral Therapy (CBT): The gold-standard psychotherapy for BED, helping you identify and change thought patterns that trigger binges
• Dialectical Behavior Therapy (DBT): Focuses on emotional regulation and distress tolerance
• Interpersonal Therapy (IPT): Addresses relationship issues that may contribute to disordered eating

Many of these therapies are also available via telehealth.

Nutritional Counseling

A registered dietitian specializing in eating disorders can help you:

• Develop regular eating patterns
• Challenge food rules and restrictions that may trigger binges
• Learn intuitive eating principles
• Address nutritional deficiencies

Support Groups

Peer support—whether through organizations like Overeaters Anonymous or BED-specific groups—can be invaluable. Many support groups now meet virtually.

Lifestyle Modifications

• Stress management techniques
• Sleep hygiene improvement
• Physical activity (focusing on movement for wellness, not punishment)
• Mindfulness practices

At Klarity Health, our providers take a holistic approach to BED treatment. While we can prescribe medication when appropriate, we’ll also discuss therapy options, provide nutritional guidance, and connect you with additional resources to support your recovery.

Getting Started with Telehealth BED Treatment

Step 1: Find a Reputable Provider

Research telehealth platforms that:

• Employ licensed psychiatrists, psychiatric nurse practitioners, or other mental health prescribers
• Specialize in or have experience with eating disorders
• Accept your insurance (or offer transparent cash pricing)
• Have good reviews and proper credentials
• Operate legally in your state

Step 2: Schedule an Evaluation

Book an initial consultation. Before your visit:

• Prepare to discuss your eating patterns honestly
• Write down questions about treatment options
• Gather information about your medical history and current medications
• Consider tracking binge episodes for a week or two to give your provider concrete data

Step 3: Be Prepared for a Thorough Assessment

Expect your provider to:

• Ask detailed questions about your eating behaviors
• Screen for other mental health conditions (depression, anxiety often co-occur with BED)
• Review medical contraindications
• Discuss various treatment options, not just medication
• Explain risks and benefits of any proposed medication

Step 4: Make an Informed Decision

You should never feel pressured to start medication immediately. It’s okay to:

• Ask for time to think about treatment options
• Request references to research studies supporting off-label use
• Discuss starting with therapy before or instead of medication
• Get a second opinion

Step 5: Commit to Follow-Through

If you start medication:

• Attend all scheduled follow-up appointments
• Report side effects or concerns promptly
• Take medication as prescribed (not ‘as needed’)
• Be patient—these medications often take weeks to show full effects
• Consider complementary therapy for best outcomes

Real-World Success: What Treatment Outcomes Look Like

It’s important to have realistic expectations. BED medications typically:

• Reduce binge frequency by 50-70% in responsive patients (not complete elimination)
• Take 4-8 weeks to show meaningful effects
• Work best when combined with therapy
• May support weight management, but aren’t primarily weight-loss drugs

Recovery from BED is a journey, not a destination. Some people achieve complete remission; others manage symptoms effectively while still having occasional difficult periods. Medication can be a valuable tool, but it’s rarely a magic bullet.

Your Rights as a Telehealth Patient

Right to Quality Care

You deserve the same standard of care via telehealth as you would receive in person. This means:

• Comprehensive evaluation before prescribing
• Clear communication about diagnosis and treatment
• Respect for your autonomy and informed consent
• Access to your medical records
• Ability to ask questions and receive thoughtful answers

Right to Privacy

Telehealth platforms must comply with HIPAA and state privacy laws:

• Encrypted, secure video platforms
• Protected health information kept confidential
• Clear privacy policies you can review

Right to Continuity

If you’re not satisfied with your telehealth provider, you can:

• Request your records be transferred to another provider
• Discontinue services (though if on medication, work with your provider on safe discontinuation)
• File complaints with state medical boards if you believe care was substandard

Looking Ahead: The Future of Telehealth for Eating Disorders

As telehealth becomes more established, we’re likely to see:

• Better integration with in-person care (hybrid models)
• Improved technology for remote monitoring (apps tracking eating patterns, mood)
• Expanded insurance coverage as parity laws solidify
• More specialized providers entering the telehealth space
• Clearer regulations as states and the DEA finalize permanent rules

The temporary nature of some current regulations (like the DEA’s controlled substance flexibilities) creates some uncertainty, but the trajectory is clear: telehealth is here to stay. For non-controlled medications like those used for BED, access will likely remain broad and become even more streamlined.

Final Thoughts: Empowering Your Recovery Journey

Getting help for Binge Eating Disorder takes courage. Whether you choose telehealth or in-person care—or a combination—the most important step is taking that first step toward treatment.

Telehealth has democratized access to BED care, connecting people with specialists and evidence-based treatments regardless of geography. The regulatory framework supporting telehealth prescribing of medications like Topamax and Wellbutrin is now well-established and stable. You can pursue treatment confidently, knowing that:

• Federal and most state laws fully support telehealth prescribing for non-controlled BED medications
• Quality telehealth providers follow the same standards as in-person care
• You have options—from provider type (MD, NP) to treatment modality (medication, therapy, or both)
• Your privacy and safety are protected by multiple layers of regulation

If you’re struggling with binge eating, you don’t have to wait for an in-person appointment that might be weeks or months away. Quality telehealth care is accessible now.

Ready to take the next step? Klarity Health offers online consultations with board-certified providers who specialize in eating disorders and mental health conditions. Our providers can evaluate you for BED, discuss treatment options including medication when appropriate, and create a personalized care plan—all through convenient telehealth visits. We accept most major insurance plans and offer transparent cash pricing. Schedule your consultation today and start your path toward recovery.

Research Currency Statement

Verified as of: January 4, 2026

• DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

• States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.

• Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

• ⚠️ Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

Top 5 Citations

1. HHS Press Office. ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026.’ U.S. Department of Health and Human Services, January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Sheppard Health Law Blog, August 2025. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ CCHP Telehealth Policy Database, November-December 2025. https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Health Jobs Nationwide Blog, 2025. https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. U.S. Food and Drug Administration / DailyMed. ‘Bupropion Hydrochloride Extended-Release Tablets Label.’ National Library of Medicine, latest revision. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12